Hongling Zhao

机构：Institute for Stem Cell Biology and Regenerative Medicine, Chinese Society for Electrical Engineering · ORCID：0009-0003-1055-1295

发表论文 65 篇 · 总被引 702 次 · h-index 15

代表论文

• Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition (2022 · British Journal of Cancer · 被引 50)
• Status of diagnosis and preventative treatment for primary headache disorders: real-world data of unmet needs in China (2023 · The Journal of Headache and Pain · 被引 37)
• Targeted inhibition of SCFSKP2 confers anti-tumor activities resulting in a survival benefit in osteosarcoma (2024 · Oncogene · 被引 23)
• MRI-based habitat radiomics combined with vision transformer for identifying vulnerable intracranial atherosclerotic plaques and predicting stroke events: a multicenter, retrospective study (2025 · EClinicalMedicine · 被引 22)
• Standard: Human gastric organoids (2025 · Cell Regeneration · 被引 11)
• The prevalence and clinical features of fibromyalgia in Chinese hospital patients with primary headache: The survey of fibromyalgia comorbid with headache (2023 · Headache The Journal of Head and Face Pain · 被引 9)